Brief: Yichang Hec Changjiang Pharmaceutical Sees Increase In Profit Attributable Of No Less Than 120% For Year
24/02/2020 10:46
Feb 24 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* YICHANG HEC CHANGJIANG PHARMACEUTICAL SEES INCREASE IN
PROFIT
ATTRIBUTABLE OF NO LESS THAN 120% FOR YEAR
* EXPECTED RESULT DUE TO CONTINUOUS INCREASE IN SALES
REVENUE OF
KEWEI, CO'S CORE PRODUCT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3HB1b2
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million